pharma FDA Accelerated Approval: Is Ultomiris the Best Option? October 22, 2026 Vincent Hughes FDA accelerated approval has been granted to Ultomiris for IgAN treatment, offering new hope for patients.
healthcare Cancer Treatment Costs India: What Are the Real Solutions? October 19, 2026 Vincent Hughes Cancer treatment costs India are rising. Can Article 21 provide effective price regulation?
pharma FDA Approval for Liver Cancer Drug: Clear Path Ahead October 15, 2026 Vincent Hughes FDA approval liver cancer drug is anticipated this year as HLB resolves manufacturing issues.
Pharmaceuticals Price Caps on Life-Saving Drugs: A Smart Step Forward October 10, 2026 Vincent Hughes Price caps on life-saving drugs are crucial for patient access and affordability.
Pharmaceuticals Keytruda patent claims face tough fight with proven strategies October 7, 2026 Vincent Hughes Keytruda patent claims are creating challenges for Halozyme and Merck in Europe.
Pharma News SpyGlass Pharma stock: Best Buy Rating from Stifel October 2, 2026 Vincent Hughes SpyGlass Pharma stock receives a proven Buy rating from Stifel amid acquisition news.